Seeking Alpha

Biogen Idec (BIIB -0.2%) says it's collaborating with several leading academic research centers...

Biogen Idec (BIIB -0.2%) says it's collaborating with several leading academic research centers to leverage a range of scientific techniques and disciplines to identify new approaches to treating amyotrophic lateral sclerosis. It is anticipated that coordinating research and sharing results across a number of different disciplines will greatly accelerate the understanding of the mechanisms of the disease and the development of new treatments.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs